PIP
SNY icon

Philadelphia Investment Partners’s Sanofi SNY Stock Holding History

Philadelphia Investment Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.44K Buy
151
+6
+4% +$268 ﹤0.01% 146
2026
Q1 		$7K Buy
+145
New +$6.76K ﹤0.01% 145

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Philadelphia Investment Partners's SNY Position: Q2 2026 in Review

Philadelphia Investment Partners increased its Sanofi (SNY) stake by 4.1% in Q2 2026, buying an estimated $268 and bringing the position to 151 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #146.

Philadelphia Investment Partners first reported a position in SNY in Q1 2026 and has held it in 2 quarters since. The position peaked at $7K in Q1 2026. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Philadelphia Investment Partners held 151 shares of Sanofi worth $6.44K as of Q2 2026.
  • Philadelphia Investment Partners bought 6 Sanofi shares in Q2 2026, an estimated $268.
  • Sanofi made up ﹤0.01% of Philadelphia Investment Partners's portfolio in Q2 2026, its #146 holding.
  • Philadelphia Investment Partners first reported a position in Sanofi in Q1 2026 and has held it in 2 quarters since.
  • Philadelphia Investment Partners's Sanofi position peaked at $7K in Q1 2026.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Philadelphia Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.